Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Faramand, Rawan
[Clear All Filters]
2024
Ionescu F
,
David JC
,
Ravichandran A
,
Sallman DA
,
Sweet K
,
Komrokji RS
,
Chan O
,
Kuykendall A
,
Padron E
,
Faramand R
, et al.
Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant.
Clin Lymphoma Myeloma Leuk. 2024.
PubMed
Google Scholar
2023
Rejeski K
,
Perez A
,
Iacoboni G
,
Blumenberg V
,
Bücklein VL
,
Völkl S
,
Penack O
,
Albanyan O
,
Stock S
,
Müller F
, et al.
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion.
Sci Adv. 2023;9(38):eadg3919.
PubMed
Google Scholar
Elmariah H
,
Otoukesh S
,
Kumar A
,
Ali H
,
Arslan S
,
Shouse G
,
Pourhassan H
,
Nishihori T
,
Faramand R
,
Mishra A
, et al.
Sirolimus is an acceptable alternative to tacrolimus for graft-versus-host disease prophylaxis after haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide.
Transplant Cell Ther. 2023.
PubMed
Google Scholar